Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Gains from Sales and Divestitures (2016 - 2018)

Cryo Cell International's Gains from Sales and Divestitures history spans 7 years, with the latest figure at $50550.0 for Q3 2018.

  • Quarterly results put Gains from Sales and Divestitures at $50550.0 for Q3 2018, up 47.06% from a year ago — trailing twelve months through Aug 2018 was $50550.0 (up 47.06% YoY), and the annual figure for FY2017 was $83238.0, down 31.95%.
  • Gains from Sales and Divestitures for Q3 2018 was $50550.0 at Cryo Cell International, up from $41797.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $122326.0 in Q4 2016 to a low of $5625.0 in Q1 2016.
  • The 5-year median for Gains from Sales and Divestitures is $34580.0 (2015), against an average of $44298.3.
  • The sharpest move saw Gains from Sales and Divestitures skyrocketed 261.86% in 2016, then plummeted 63.76% in 2017.
  • Year by year, Gains from Sales and Divestitures stood at $75409.0 in 2014, then plummeted by 54.14% to $34580.0 in 2015, then soared by 253.75% to $122326.0 in 2016, then plummeted by 31.95% to $83238.0 in 2017, then tumbled by 39.27% to $50550.0 in 2018.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $50550.0, $41797.0, and $18957.0 for Q3 2018, Q2 2018, and Q1 2018 respectively.